Dual-Targeted Self-Adjuvant Heterocyclic Lipidoid@Polyester Hybrid Nanovaccines for Boosting Cancer Immunotherapy
Year: 2024
Type: article
Source: ACS Nano
Institutions: Shenyang Pharmaceutical University, Jilin University
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
Award: G1162229700
OpenAlex ID: W4399367308
